Organoids were cultured from healthy donor iPSC sources and differentiated using the human iPSC-derived Cerebral Organoid ...

Recursion is advancing REC-617, a promising reversible, non-covalent CDK7 inhibitor, showing potential in treating advanced solid tumors with positive interim phase 1 data. Read more here.

(THE CONVERSATION) As research into psychedelics and their medical uses makes a comeback, scientists are having to deal with the legacy – both scientific and social – of a 40-year nearly total freeze ...

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination ...

Recurrent laryngeal injury risk was reduced with intraoperative nerve monitoring among patients with thyroid cancer undergoing thyroidectomy.

Stem-cell differentiation is the process by which a more specialised cell is formed from a stem cell, leading to loss of some of the stem cell's developmental potential. Stem-cell differentiation ...

Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).

The board of directors of Franklin Lakes-based, global medical technology company BD, has unanimously authorized BD ...

Every cell in the body normally has its fixed place as part of a tissue structure. Except for a few cell types, such as blood ...

1 Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee ... The effect of claudin-1 expression upon colonic epithelial differentiation, lineage commitment and ...